Synlait Finalises NZ$320 Million Bank Facility and Replaces $130 Million Shareholder Loan
Synlait Milk has locked in a NZ$320 million refinancing package with a broad banking syndicate and replaced its $130 million shareholder loan, while shifting its financial year-end to December to match its major shareholder.
- NZ$320 million secured refinancing package finalised
- New banking syndicate includes ANZ and multiple Chinese banks
- Replacement $130 million shareholder loan with Bright Dairy
- Balance date changed from 31 July to 31 December
- Key financial covenants set with leverage and working capital ratios
Comprehensive Refinancing Package Completed
Synlait Milk Limited (ASX:SM1, NZX:SML) has finalized a significant refinancing deal totaling NZ$320 million, bringing together a diverse syndicate of banks including ANZ, HSBC, and several major Chinese lenders such as China Construction Bank and Bank of Beijing. The package blends secured overdraft, seasonal working capital, term loans, and revolving credit facilities, with maturities primarily set for mid-2027.
The seasonal working capital facilities will reduce stepwise from NZ$146 million to NZ$86 million by March 2027, and further to NZ$26 million by June 2027, reflecting a planned deleveraging trajectory. The refinancing agreement also imposes key financial covenants including a net senior leverage ratio capped at 3.0x, a working capital ratio that tightens from 1.50x to 1.75x after February 2027, and minimum interest cover ratios starting at 2.5x quarterly, increasing to 3.0x thereafter.
Shareholder Loan Replacement with Bright Dairy
In parallel, Synlait has executed a replacement shareholder loan agreement with Bright Dairy International Investment Limited for NZ$130 million, expected to be drawn down in early July 2026 following the completion of the bank refinancing. This replaces the previous Bright shareholder loan, a move that was foreshadowed earlier in the month and granted a waiver from NZX Listing Rule 5.2.1 to facilitate its entry and performance.
The replacement loan terms have been negotiated at arm’s length overseen by independent directors, underscoring the company’s efforts to stabilise its capital structure amid ongoing operational adjustments.
Financial Year-End Shift to Align with Majority Shareholder
Synlait’s board has resolved to change the company’s financial reporting balance date from 31 July to 31 December, aligning its year-end with Bright Dairy & Food Co., Ltd., its principal shareholder. The next balance date remains 31 July 2026, followed by a transitional five-month reporting period ending 31 December 2026. Subsequent financial years will then follow the calendar year cycle.
This shift is expected to streamline consolidated reporting and potentially enhance transparency for investors tracking Synlait’s performance alongside its Chinese partner’s operations. The company is still finalising the reporting approach for the transitional period and will provide updates in due course.
Bottom Line?
Synlait’s refinancing and shareholder loan replacement mark key steps in its financial reset, but the impact of new covenants and the transitional reporting period will be critical to monitor through 2027.
Questions in the middle?
- How will Synlait manage covenant testing starting June 2027 under the new financial structure?
- What financial disclosures will emerge from the five-month transitional reporting period ending December 2026?
- To what extent will the alignment with Bright Dairy influence Synlait’s strategic and operational decisions?
